Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients.

J Exp Clin Cancer Res · 2015 · PMC4447018 · PMID 25986064

Europe PMC DOI

hedged sentences

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

of borderline significancep = 0.053so close (0.05 < p ≤ 0.1)

An adverse association of borderline significance was seen in case of mem-PankoMab-GEXTM and Her2 positivity (p = 0.053).

also in 2,624 other papers

showed a trendno p-value reported

Further, staining of mem-PankoMab-GEXTM showed a trend of being negatively associated with Her2 positivity.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.